Alison Young
usatoday.com
June 14, 2012
A $214 million bioterror germ lab at the Centers for Disease Control and Prevention in Atlanta has had repeated problems with airflow systems designed to help prevent the release of infectious agents, government documents and internal e-mails show.
While the agency says no one has been infected, a biosafety expert says the problems appear to be major violations of laboratory operating standards.
The area of the building with problems involves Biosafety Level 3 labs that can be used for experiments involving anthrax, dangerous strains of influenza, the SARS coronavirus, monkeypox and other microbes that have the potential to be used as bioweapons.
No comments:
Post a Comment